BCR-ABL1 and Beyond

Pathology - United States
doi 10.1016/j.pathol.2020.01.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BCR-ABL1-independent PI3Kinase Activation Causing Imatinib-Resistance

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2011English

BCR/ABL1 -Like Acute Lymphoblastic Leukemia: How to Diagnose and Treat?

Cancer
Cancer ResearchOncology
2018English

Expansion of BCR/ABL1 + Cells Requires PAK2 but Not PAK1

British Journal of Haematology
Hematology
2017English

Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2016English

Γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Clinical and Prognostic Significance of E1a2 BCR-ABL1 Transcript Subtype in Chronic Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2017English

The Proximal Signaling Network of the BCR-ABL1 Oncogene Shows a Modular Organization

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Current Pre-Clinical and Clinical Advances in the BCR-ABL1-positive and -Negative Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy